X4 Pharmaceuticals (XFOR) Receivables - Other (2017 - 2025)
X4 Pharmaceuticals (XFOR) reported Receivables - Other of $715,000 for Q3 2025, down 33.4% from $1.07 million a year earlier and down 0.7% from the prior quarter.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Receivables - Other (2017 - 2025) Analysis & Trends
At the end of FY2024, X4 Pharmaceuticals posted Receivables - Other of $640,000, up 13.9% from FY2023.
- Receivables - Other has a five-year compound annual growth rate of -20.4% (FY2019 to FY2024).
- By year, Receivables - Other came in at $562,000 in FY2023 (-51.2%), $1.15 million in FY2022 (+54.2%), $747,000 in FY2021 (-18.5%) and $917,000 in FY2020 (-54.1%).
- Five-year quarterly Receivables - Other spans a low of $393,000 in Q3 2023 and a high of $1.15 million in Q4 2022.
- Year over year, Receivables - Other has now declined in each of the last three quarters, with growth averaging 11.5% over the last eight quarters.
- The high point for year-over-year Receivables - Other in five years was Q3 2024 (growth of 173.0%); the low point was Q3 2023 (a decline of 56.8%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $720,000 (Q2 2025), $665,000 (Q1 2025) and $640,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | X4 Pharmaceuticals | 381.56 Mn | -317.13 Mn | 7.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 715,000.00 |
| Jun 30, 2025 | 720,000.00 |
| Mar 31, 2025 | 665,000.00 |
| Dec 31, 2024 | 640,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 854,000.00 |
| Mar 31, 2024 | 702,000.00 |
| Dec 31, 2023 | 562,000.00 |
| Sep 30, 2023 | 393,000.00 |
| Jun 30, 2023 | 820,000.00 |
| Mar 31, 2023 | 658,000.00 |
| Dec 31, 2022 | 1.15 Mn |
| Sep 30, 2022 | 909,000.00 |
| Jun 30, 2022 | 843,000.00 |
| Mar 31, 2022 | 868,000.00 |
| Dec 31, 2021 | 747,000.00 |
| Sep 30, 2021 | 646,000.00 |
| Jun 30, 2021 | 1.05 Mn |
| Mar 31, 2021 | 768,000.00 |
| Dec 31, 2020 | 917,000.00 |
API Access
X4 Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=XFOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "XFOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=XFOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();